Rangering i aksjer
#37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Aksjekurs
$0.00060315
Sist synkronisert: 2024-09-27
Handel Amniotics AB (publ) (AMNI)
Pris AMNI pris med markedsverdi på B
Markedsverdi av Amniotics AB (publ)(AMNI)
Markedsverdi: $1.65M
Per August 2026 har Amniotics AB (publ) en markedsverdi på $1.65M. Dette gjør Amniotics AB (publ) til det 37511th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Amniotics AB (publ) fra 2021 til 2026
AMNI sammenlignet med topp 5 mest populære stocks
| Pris på AMNI |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+330,719,226.46%
|
|
|
|
|
$4.490T
|
+272,371,960.14%
|
|
|
|
|
$4.162T
|
+252,498,403.81%
|
|
|
|
|
$3.676T
|
+223,012,921.38%
|
|
|
|
|
$2.833T
|
+171,856,957.95%
|
